Digitally Sick are in isolation and therefore are going to be ramping up the number of podcasts as sharing and communicating is more important than ever.

Today we have a quick chat about how the terrible global catastrophe of the Coronavirus could impact the digital transformation of pharma. Although we need to be thinking about our frontline healthcare professionals and everyone else helping to support us in this time, we thought it was worth talking about possible implications. We discuss the continued reliance on face to face meetings, congress, advisory boards and also the focus on company representatives in sales and scientific liaison. Should we be further ahead in digitally transforming our business in 2020 and could this be a tipping point? A pivot point to a new velocity? Alex Butler and Faisal Ahmed discuss